about
Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.Response to statin therapy in obstructive sleep apnea syndrome: a multicenter randomized controlled trial.Heat stress preconditioning and delayed myocardial protection: what is new?Cellular protection by erythropoietin: new therapeutic implications?Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials.Severe Central Sleep Apnea Associated With Chronic Baclofen Therapy: A Case Series.Impact of concomitant medications on obstructive sleep apnoea.Acquired central hypoventilation following Listeria monocytogenes rhombencephalitis.Erythropoietin improved initial resuscitation and increased survival after cardiac arrest in rats.Drugs and obstructive sleep apnoea.Atorvastatin protects against deleterious cardiovascular consequences induced by chronic intermittent hypoxia.Chronic intermittent hypoxia increases infarction in the isolated rat heart.Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea.Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat.Erythropoietin pretreatment protects against acute chemotherapy toxicity in isolated rat hearts.Early pharmacological preconditioning by erythropoietin mediated by inducible NOS and mitochondrial ATP-dependent potassium channels in the rat heart.Continuous positive airway pressure treatment impact on memory processes in obstructive sleep apnea patients: a randomized sham-controlled trial.Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance database.Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease.Prevalence of obesity hypoventilation syndrome in ambulatory obese patients attending pathology laboratories.Severe excessive daytime sleepiness induced by hydroxyurea.Intermittent hypoxia in obese Zucker rats: cardiometabolic and inflammatory effects.Comparison of continuous positive airway pressure and bosentan effect in mildly hypertensive patients with obstructive sleep apnoea: A randomized controlled pilot study.Evaluation of the effect of one large dose of erythropoietin against cardiac and cerebral ischemic injury occurring during cardiac surgery with cardiopulmonary bypass: a randomized double-blind placebo-controlled pilot study.Continuous Positive Airway Pressure Reduces Night-Time Blood Pressure and Heart Rate in Patients With Obstructive Sleep Apnea and Resistant Hypertension: The RHOOSAS Randomized Controlled Trial.What is the best treatment strategy for obstructive sleep apnoea-related hypertension?Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary DiseaseAcute intermittent hypoxia improves rat myocardium tolerance to ischemiaDeleterious myocardial consequences induced by intermittent hypoxia are reversed by erythropoietinComparison of the effects of zinc alone and zinc associated with selenium and vitamin E on insulin sensitivity and oxidative stress in high-fructose-fed ratsFructose-fed rat hearts are protected against ischemia-reperfusion injuryTicagrelor and Central Sleep ApneaDiagnosis and management of central sleep apnea syndromeContribution of obstructive sleep apnoea to arterial stiffness: a meta-analysis using individual patient dataDrugs influencing acid base balance and bicarbonate concentration readingsGabapentinoids and sleep apnea syndrome: a safety signal from the WHO pharmacovigilance databasePrevalence of obstructive sleep apnea syndrome in patients with lymphedema referred for complete decongestive therapyLong-term adherence to ambulatory initiated continuous positive airway pressure in non-syndromic OSA childrenPartial failure of CPAP treatment for sleep apnoea: Analysis of the French national sleep databaseLiver Fibrosis, Sleep Apnea and Cardiovascular Events in Stroke Patients
P50
Q31023532-1926AE2D-3AB5-402B-AB05-C535904E120AQ34152828-A0D2E45E-B5DF-481D-8312-E657F86DC602Q35601870-0467F357-35AF-4BE9-8A2B-6BC8F4230AB7Q36918518-B16F715D-6F2A-421A-8AA2-F0AE21EADEDCQ38249122-ABC06661-2B3F-468D-9B4F-089D491016C4Q38870000-D6DEFE1C-C046-4255-A917-739D172F1E39Q38979483-D63C0312-9FD9-4B17-93EA-E62A9D8F65ABQ40372081-F20C165E-800E-44D7-ADC2-E4CF68158EA1Q43664144-4405B9D2-2AA3-4326-87C6-A40B97C8E929Q43697957-8D9A623B-DECE-4803-831F-228FC4E251EAQ45018464-D0F70B25-F502-47A0-9543-20681C7A7C54Q45200745-981B8309-B35A-4999-B37E-3F09D01FB289Q46055084-3CDF88FE-5072-4FB9-B578-8F00042A73EEQ46568094-2C610438-4B5F-4798-822C-803F751AA0A9Q46835198-DFB1DED6-AE9C-42EE-8425-D84C5CED78C8Q46920535-F6889AF5-BD5B-46ED-9475-A92E05378239Q47639427-0C1F637F-C6C9-45FF-B485-AE5BE895BF66Q47645895-D1A272AD-E180-4055-A949-E9B2317D5803Q47722561-715DC9EE-7C09-491E-A18E-0D5C9A590D81Q47743146-28717556-F0FE-4DE5-8DF4-1A8EE08899BFQ47782098-FA1C18D0-F2E4-4D70-9C90-734CAEB60570Q47799206-F3EFCD52-E414-4FFD-8639-32574B5349F6Q47911630-76B612D4-93D5-4376-9DAD-B7E84BF5FD2EQ48891343-40211E96-8459-4AF1-AC9E-8F0068A4453BQ55067395-D6102A07-2093-4A2D-8D38-20B021A2C83BQ57462950-67D48329-C437-40CC-8331-EE90815B95FDQ58589460-502B1545-13D9-415F-97A7-CBBE1544806AQ59419656-EEA4DE8A-375A-46EE-BCC5-B573E13BBC78Q79426487-33FA2A96-8EE4-4529-897E-A023A20288FEQ80326035-D95355A9-CC55-49C8-BB48-5ABE0EAEDA6DQ82973667-3AD8B564-5B2F-447A-81C9-454EA7CD5B98Q88719620-7CB3DA46-2C9D-47FC-83DD-2A9AFF908D7AQ90242737-BA56C76B-A5E1-47EE-9AD3-18262808931FQ90386492-A0D7F191-F9A8-4A22-A0F6-39018034C378Q90607945-AA7E68C9-B2B7-48CA-BF5A-F2457F0B8DE8Q90780919-BC85F7CB-B8D6-40E2-A8EF-82894AE17DF4Q90855898-752D7B74-3B02-4A82-8811-6AB3959B82B7Q91239013-1D23B5CA-3058-461E-B965-5ABF862C8F18Q92125492-62E4FBB1-5851-47D6-865D-CD6DF628A030Q92878259-F1358C9D-FF06-42D7-9F2E-BFD2F40E4336
P50
description
investigador
@es
researcher
@en
name
Marie Joyeux-Faure
@en
Marie Joyeux-Faure
@nl
type
label
Marie Joyeux-Faure
@en
Marie Joyeux-Faure
@nl
prefLabel
Marie Joyeux-Faure
@en
Marie Joyeux-Faure
@nl
P31
P496
0000-0001-8298-0038